Dynamic Technology Lab’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Dynamic Technology Lab’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-14,421	Closed	-$55K	–	1507
2020 Q1	$55K	Buy	+14,421	New	+$62.1K	0.01%	939
2019 Q1	–	Sell	-25,867	Closed	-$108K	–	1461
2018 Q4	$108K	Buy	+25,867	New	+$132K	0.02%	890
2017 Q1	–	Sell	-16,596	Closed	-$144K	–	1394
2016 Q4	$144K	Buy	+16,596	New	+$123K	0.04%	776
2016 Q2	–	Sell	-28,359	Closed	-$123K	–	1279
2016 Q1	$123K	Buy	+28,359	New	+$126K	0.03%	818
2015 Q3	–	Sell	-18,500	Closed	-$138K	–	1131
2015 Q2	$138K	Buy	+18,500	New	+$112K	0.05%	674

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Dynamic Technology Lab's PGNX Position: Q2 2020 in Review

Dynamic Technology Lab sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 14,421 shares — an estimated $55K sold.

Dynamic Technology Lab first reported a position in PGNX in Q2 2015 and held it in 5 quarters. The position peaked at $144K in Q4 2016. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Dynamic Technology Lab reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Dynamic Technology Lab sold 14,421 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $55K.
Dynamic Technology Lab first reported a position in Progenics Pharmaceuticals Inc in Q2 2015 and held it in 5 quarters.
Dynamic Technology Lab's Progenics Pharmaceuticals Inc position peaked at $144K in Q4 2016.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Dynamic Technology Lab's 13F filing for Q2 2020, filed 14 Aug 2020.